Maccura shareholder plans stake reduction; notes capital decrease

Maccura Biotechnology (SZSE:300463) faces significant shareholder activity as Guo Lei, a holder of more than 5% of the company's shares, and his concerted actors, including Shanghai Axing Investment Management Co., plan to reduce their holdings. The pre-disclosure announcement reveals intentions to decrease their stake by no more than 16,327,928 shares, representing 2.68% of the current total share capital (excluding repurchased shares). This reduction will occur via centralized bidding or block trades within a 90-day period after a 15-day waiting period following the announcement.